CA1045976A - Medicament sous forme de membrane liquide encapsulee et utilisation - Google Patents

Medicament sous forme de membrane liquide encapsulee et utilisation

Info

Publication number
CA1045976A
CA1045976A CA223,683A CA223683A CA1045976A CA 1045976 A CA1045976 A CA 1045976A CA 223683 A CA223683 A CA 223683A CA 1045976 A CA1045976 A CA 1045976A
Authority
CA
Canada
Prior art keywords
emulsion
phase
oil
toxin
exterior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA223,683A
Other languages
English (en)
Other versions
CA223683S (en
Inventor
William J. Asher
Adam L. Shrier
Norman N. Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ExxonMobil Technology and Engineering Co
Original Assignee
Exxon Research and Engineering Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exxon Research and Engineering Co filed Critical Exxon Research and Engineering Co
Application granted granted Critical
Publication of CA1045976A publication Critical patent/CA1045976A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA223,683A 1974-05-02 1975-04-02 Medicament sous forme de membrane liquide encapsulee et utilisation Expired CA1045976A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46629374A 1974-05-02 1974-05-02

Publications (1)

Publication Number Publication Date
CA1045976A true CA1045976A (fr) 1979-01-09

Family

ID=23851228

Family Applications (1)

Application Number Title Priority Date Filing Date
CA223,683A Expired CA1045976A (fr) 1974-05-02 1975-04-02 Medicament sous forme de membrane liquide encapsulee et utilisation

Country Status (5)

Country Link
CA (1) CA1045976A (fr)
DE (1) DE2518742C2 (fr)
FR (1) FR2269329A1 (fr)
IL (1) IL47003A (fr)
NL (1) NL7505219A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4875927A (en) * 1987-01-13 1989-10-24 Imperial Chemical Industries Plc Formulation process

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3138107A1 (de) * 1981-09-24 1983-04-07 Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg Verfahren zur entfernung von stoffen aus waessrigen loesungen sowie vorrichtung zur durchfuehrung des verfahrens
FR2840218B1 (fr) * 2002-06-04 2004-08-13 Centre Nat Rech Scient Emulsions simples et multiples destinees a la detoxication de l'organisme ou de surfaces

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538216A (en) * 1964-02-20 1970-11-03 Lab De Rech Physiques S A R L Injectable compositions of a drug suspended in an emulsion
GB1144225A (en) * 1965-09-07 1969-03-05 Dow Chemical Co Preparation of medicinal capsule shells from hydroxyalkyl-alkyl cellulose ethers

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4875927A (en) * 1987-01-13 1989-10-24 Imperial Chemical Industries Plc Formulation process

Also Published As

Publication number Publication date
IL47003A (en) 1978-09-29
NL7505219A (nl) 1975-11-04
DE2518742C2 (de) 1986-10-16
DE2518742A1 (de) 1975-11-13
IL47003A0 (en) 1975-06-25
FR2269329A1 (en) 1975-11-28
FR2269329B1 (fr) 1978-10-06

Similar Documents

Publication Publication Date Title
US4183918A (en) Detoxifying-medicinal emulsions
US5371109A (en) Controlled release composition for a biologically active material dissolved or dispersed in an L2-phase
EP0314689B1 (fr) Composition a liberation regulee pour une substance biologiquement active dissoute ou dispersee dans une phase dite phase l2
Ramadas et al. Lipoinsulin encapsulated alginate-chitosan capsules: intestinal delivery in diabetic rats
EP0550615B1 (fr) Vehicules de liberation de medicaments en suspension dans un support perfluore non aqueux
US4808408A (en) Microcapsules prepared by coacervation
JP3459634B2 (ja) 液状活性物質のコアを無機質シェルにより包囲させてなるカプセルの製造方法
US5093198A (en) Adjuvant-enhanced sustained release composition and method for making
JP2758198B2 (ja) ゲル化乳濁粒子およびこれを含む組成物
US4244816A (en) Liquid membrane capsule systems resistant to coalescence by means of an irreversible coating
CA1204058A (fr) Microcapsules doubles
US4183960A (en) Detoxification by means of the controlled, in vivo secretion triggered rupture of liquid membrane capsules
Muhammad et al. A review on nanoparticle-based technologies for biodetoxification
EP0199362A2 (fr) Système et dispositif pour la libération retardée et par à-coups de substances biologiquement actives
AU625857B2 (en) Gelcores
CN104398478B (zh) 兽用药物的复乳型载体及其应用
US6977171B1 (en) Detoxification and decontamination using nanotechnology therapy
US5908636A (en) Fill material for soft gelatin pharmaceutical dosage form containing an antiflatulent
US20070219127A1 (en) Cyclosporin a compositions
US5510117A (en) Entrapment vehicle and method
EP0126583B1 (fr) Procédé de micro-encapsulation par coacervation et les microcapsules préparées ainsi
DE2518742C2 (de) Im Magen-Darm-Trakt beständige Wasser-in-Öl-Emulsionen
CN1937990B (zh) 含有复合内相的多泡沫分散体
CN108685871A (zh) 一种吉他霉素微胶囊的制备方法
WO1994008566A1 (fr) Vehicule et procede d'emprisonnement de matieres actives